ChemoCentryx
CCXI
#3561
Rank
HK$29.08 B
Marketcap
HK$404.48
Share price
0.00%
Change (1 day)
33.72%
Change (1 year)

Earnings for ChemoCentryx (CCXI)

Earnings in 2022 (TTM): -HK$1.03 Billion

According to ChemoCentryx's latest financial reports the company's current earnings are HK$37.2 Million. In 2021 the company made an earning of -HK$1.01 Billion a decrease over its 2020 earnings that were of -HK$0.42 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for ChemoCentryx from 2011 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -HK$1.03 Billion1.69%
2021 -HK$1.01 Billion144.84%
2020 -HK$0.42 Billion-1.18%
2019 -HK$0.42 Billion45.17%
2018 -HK$0.29 Billion-305.69%
2017 HK$0.13 B-144.7%
2016 -HK$0.32 Billion-15.52%
2015 -HK$0.37 Billion0.85%
2014 -HK$0.37 Billion21.47%
2013 -HK$0.31 Billion-1.24%
2012 -HK$0.31 Billion906.88%
2011 -HK$30.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
HK$14.81 B-1,557.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$12.91 B-1,371.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$72.53 B-7,238.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
HK$62.49 B-6,250.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.03 B-24,905.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$64.13 B-6,412.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.20 B-9,175.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$13.78 B-1,456.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
HK$179.63 B-17,779.94%๐Ÿ‡บ๐Ÿ‡ธ USA